baber/WOPTO huggingface dataset:
Patent DE-69511854-T2 (DE)
Inventor: HILTUNEN MATTI
IPC: F23C99/00
Filed: 1995-04-12
Granted: 2000-02-17
Abstract: A method of reducing the nitrogen oxide level in the flue gases issuing from combustion units by introduction of reducing agents into contact with gases containing nitrogen oxides in first and second reducing stages, is provided. The first reducing stage is a non-catalytic stage (e.g. at temperatures over 800 DEG  C.), while the second stage is a catalytic stage (e.g. at temperatures of about 300 DEG -400 DEG  C.). A steam generation boiler with improved nitrogen reduction facilities is also provided. The amount of nitrogen oxides in the hot gases is reduced in the combination of the first and second reducing stages while producing steam in a steam generation boiler system, thus resulting in gases essentially free from nitrogen oxides while eliminating the possibility of NH3 (or other reducing agent) slip in the exhausted flue gases. Heat transfers in a convection section as used to establish stabilized temperature conditions for catalytic reduction.
Patent DE-69513730-T2 (DE)
Inventor: SATO YASUE
IPC: H01J29/08
Filed: 1995-06-07
Granted: 2000-05-11
Abstract: A flat panel image-forming apparatus comprises a rear plate (1) including electron emitting devices (2) on its surface and a face plate (4) including a fluorescent film (5). The face plate and rear plate are assembled and sealed with an outer frame. Spacers are provided for mechanical rigidity. The assembled structure is evacuated by means of vent tubes (9). To facilitate evacuation in a short time, the spacers are arranged in rows and columns and are staggered in position relative to each other, in alternate rows and columns, in a zigzag pattern, and do not lie on straight lines connecting any two of the vent tubes. <IMAGE>
Patent DE-69514574-T2 (DE)
Inventor: AULANKO ESKO
IPC: B66B11/00
Filed: 1995-06-13
Granted: 2000-09-07
Abstract: An elevator machinery (1) with a disc type motor is mounted on one of the guide rails (6) of the elevator car or counterweight. The guide rail (6) constitutes a part adding to the mechanical strength of the elevator machinery. The vertical forces applied to the traction sheave (4) by the elevator ropes are passed to the guide rail (6) via the rolling center of a bearing. The elevator machinery is provided with a damping system to absorb vibrations and oscillations. The elevator machinery (1) of the invention is light in weight, needs only a small space when mounted and is inexpensive to manufacture. <IMAGE>
Patent DE-69518988-T2 (DE)
Inventor: HOFS WILHELMUS
IPC: D01D5/16
Filed: 1995-12-20
Granted: 2001-04-05
Abstract: A process for manufacturing continuous polyester filament yarn for technical applications from a polymer over 90% of the chains of which are composed of ethylene terephthalate units, via a one-step spinning process, with the undrawn filaments having a crystallinity smaller than 16% and the yarn being wound at a rate larger than 6000 m/min. The yarn obtained in this fashion is particularly suitable for use as reinforcing material in rubber articles, notably as reinforcing material in pneumatic tires for cars. The polyester filament yarn can be used to make cords of uncommonly high dimensional stability and a unique combination of breaking tenacity, shrinkage, and breaking toughness.
Patent DE-69525241-T2 (DE)
Inventor: JANS EUGEEN
IPC: A61K47/00
Filed: 1995-02-10
Granted: 2002-08-29
Abstract: PCT No. PCT/EP95/00489 Sec. 371 Date Jul. 9, 1996 Sec. 102(e) Date Jul. 9, 1996 PCT Filed Feb. 10, 1995 PCT Pub. No. WO95/22325 PCT Pub. Date Aug. 24, 1995The present invention relates to pharmaceutical compositions containing as active ingredient micronized nebivolol of formula (I) and ways of preparing said compositions.    <IMAGE>  (1)    <IMAGE>
Patent DE-69528525-T2 (DE)
Inventor: KATDARE V
IPC: A61K31/66
Filed: 1995-04-24
Granted: 2003-11-27
Abstract: Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by wet granulation tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease. These compositions are prepared without the addition of binder; instead, the drug itself acts as a binder.
Patent DE-69607191-T2 (DE)
Inventor: THOMSON ELIZABETH
IPC: A61P29/00
Filed: 1996-10-07
Granted: 2000-09-28
Abstract: Specific binding members comprising human antibody antigen binding domains specific for human transforming growth factor beta (TGF beta ) bind specifically isoforms TGF beta 2 and TGF beta 1 or both, preferentially compared with TGF beta 3. Specific binding members may be isolated and utilised in the treatment of disease, particularly fibrotic disease and also immune/inflammatory diseases. Therapeutic utility is demonstrated using in vitro and in vivo models. Full sequence and binding information is provided, including epitope sequence information for a particularly advantageous specific binding member which binds the active form of TGF beta 2, neutralising its activity, but does not bind the latent form.
Patent DE-69608429-T2 (DE)
Inventor: ASHAUER KARIN
IPC: A21D13/08
Filed: 1996-03-04
Granted: 2001-01-25
Abstract: Bakery fat compositions, comprising: 90 - 98 wt.% of liquid oil, 0.5 - 5 wt.% of a hardened vegetable fat, having an IV < 20, 0.5 - 2 wt.% of an emulsifier, 0 - 2 wt.% of lecithin, 0.1 - 2,5 wt.% of a cold gelling thickener are particularly suitable for the preparation of cakes, provided with fruitpieces.
Patent DE-69615208-T2 (DE)
Inventor: MANE JEAN
IPC: A23L27/20
Filed: 1996-08-29
Granted: 2002-06-13
Abstract: The invention relates to refreshing compositions, flavouring compositions and ingestible and topical compositions containing at least a refreshing compound selected amongst monomenthyl succinate, alcaline metal salts of monomenthyl succinate, alcaline-earth metal salts of monomenthyl succinate and mixtures thereof. Said compositions provide a durable, bitterness-free, pleasant and refreshing effect, and said refreshing feel is different from that of other known refreshing agents. Consequently, a complementary or synergic effect can be obtained by combination with other refreshing agents. Furthermore, the succinate-based refreshing compounds according to the invention provide for an increase of alcohol feel in alcoholic drinks. Finally, the succinate-based refreshing compounds provide a refreshing taste when they are applied to filters, combustible papers and sheets for wrapping tobacco products for smoking and when they are incorporated into tobacco products for chewing or snuffing.
Patent DE-69618390-T2 (DE)
Inventor: SUGIHARA HIROKAZU
IPC: G01N27/30
Filed: 1996-06-20
Granted: 2002-09-26
Abstract: A two-dimensional sensor (1) is described including a substrate having a Si layer, a SiO2 layer and a Si3N4 layer. On the surface of the Si back side, a thin film is formed by vapor deposition for making an effect electrode. On the surface of the Si3N4 front side, a fence is attached for containing a sample cell (2), culture medium and a reference electrode. This sensor (1) is placed in an incubator (3) and a bias voltage is applied between the effect and reference electrodes. When a high frequency modulated laser beam irradiates a spot of the back side of the sensor substrate, a signal of AC photocurrent is obtained from the effect electrode. This signal corresponds to a potential alteration due to the cell activity substantially at the spot. The signal is processed in a computer (10). Therefore, the beam spot size and location, corresponding to the size and the location of the measurement electrode, can be adjusted easily by focusing or moving the laser beam. <IMAGE>
Patent DE-69618955-T2 (DE)
Inventor: COLE L
IPC: C12Q1/68
Filed: 1996-06-03
Granted: 2002-08-14
Abstract: An assay for the influenza virus endonuclease has been developed which involves DNA polymerase-catalyzed extension of the viral endonuclease cleavage product using labeled nucleotides and a DNA template containing a 3' region complementary to the product joined to a 5' region consisting of repeated residues. The DNA polymerase coupled assay does not involve gel electrophoretic separation and is amenable to high volume screening of potential inhibitors. Another key feature of the assay is that it is sensitive enough to detect 200 attomoles of product.
Patent DE-69628479-T2 (DE)
Inventor: CHEN HERBERT M K
IPC: H04M3/02
Filed: 1996-01-23
Granted: 2004-05-06
Abstract: A ring generator circuit is included in a subscriber line interface circuit (SLIC) for providing a high voltage ring signal to a plurality of ringers at the same time. The ring generator circuit includes an adder and divider circuit connected to receive a DC offset and an AC reference signal from the SLIC. The adder and divider circuit outputs a fractionalized summed signal. That signal is supplied to a full-wave rectifier, which rectifies the fractionalized summed signal so that it is always a positive voltage. The rectified signal is supplied to a switch control circuit, a first amplifier and a second amplifier. The first and second amplifiers have the same gain, but with opposite signs or polarities. The outputs of the first and second amplifiers are sent to a commutating switch, which is controlled by an output of the switch control circuit. The output of the switch control circuit is used to force the commutating switch to output a ring signal that has either a same or a reversed polarity with respect to the summed signal. <IMAGE>
Patent DE-69630786-T2 (DE)
Inventor: TARR I
IPC: C12Q1/68
Filed: 1996-04-12
Granted: 2004-09-30
Abstract: An isolated nucleic acid molecule that hybridizes under stringent conditions to SEQ ID NO:1 or its complement and to the DNA of enterohemorrhagic E. coli O157:H7 but not to the DNA of enteropathogenic E. coli O55:H7.
Patent DE-69702510-T2 (DE)
Inventor: GRANHOLM JOHAN
IPC: H01Q21/06
Filed: 1997-03-26
Granted: 2001-03-08
Abstract: PCT No. PCT/DK97/00141 Sec. 371 Date Oct. 2, 1998 Sec. 102(e) Date Oct. 2, 1998 PCT Filed Mar. 26, 1997 PCT Pub. No. WO97/38465 PCT Pub. Date Oct. 16, 1997The present invention relates to an antenna array adapted to radiate or receive electromagnetic waves of one or two polarizations with very low cross polarization and low sidelobes. An antenna array comprising many antenna elements, e.g., more than ten antenna elements, is provided in which formation of grating lobes are inhibited in selected directions of the radiation and cross polarization within the main lobe is suppressed at least 30 dB below the main lobe peak value. According to a preferred embodiment of the invention, the antenna elements of the antenna array comprise probe-fed patches, preferably rectangular patches, more preferred, square patches. Further, it is preferred that the feed probes are positioned at the axis of symmetry of the square or rectangular patches.
Patent DE-69713436-T2 (DE)
Inventor: HOSHINO TATSUO
IPC: C12N1/20
Filed: 1997-03-29
Granted: 2003-01-23
Abstract: A process for producing d-biotin comprises cultivating a microorganism of the genus Kurthia and which is resistant to biotin antimetabolites and capable of producing d-biotin in a medium under aerobic conditions, and separating the resulting d-biotin from the fermentation broth. The cultivation medium suitably contains an assimilable carbon source, a digestible nitrogen source, inorganic salts and other nutrients necessary for the growth of the microorganism at a pH of about 5-9, temperature of about 10-40 DEG C and for a duration of about 1-10 days. The preferred microorganism are Kurthia sp. 538-KA26, 538-17H4, 538-51F9 and 538-2A 13 (DSM No. 10609, 10608, 10610 and 10607, respectively), which are also new, and as such represent a further aspect of the present invention. The so-produced d-biotin is one of the essential vitamins for the nutrition of animals, plants and microorganisms, and is important as a medicine or food additive. It is produced in particularly high yield by the process of the present invention.
Patent DE-69722317-T2 (DE)
Inventor: MICELOT CLAUDE BERNARD
IPC: B65D83/16
Filed: 1997-07-11
Granted: 2004-04-29
Abstract: The safety cap and valve actuator for an aerosol container with a vertical outlet consists of a fixed dome (12). The dome fits over the top of the container and attaches to its valve rim (40). A movable dome (14) of the same shape which has an access port (48) for the valve actuator (32). The movable dome can be rotated relative to the fixed one so that the access port is open or closed, permitting or preventing the contents of the container from being discharged. The fixed dome has a central aperture and in inner cylindrical wall (38) with a side opening for the actuator (32). It also has a stepped rim and a slot to receive the lower edge of the movable dome and a projecting lug (50) on it.
Patent DE-69728826-T2 (DE)
Inventor: COHEN BEN Z
IPC: B05B11/00
Filed: 1997-07-10
Granted: 2005-04-21
Abstract: A microdispensing ophthalmic pump is provided for repeatedly delivering doses as small as 5 microliters within an angular operating range. The pump basically comprises a reservoir (12), a dispensing cap (18), an actuator (20) and a pump body (14) with a pump mechanism (16) disposed therein. The pump mechanism (16) is regulated by a limited-travel inlet check valve and a biased-closed outlet check valve. A failsafe mechanism is formed between the actuator (20) and dispensing cap (18) to prevent operation of the pump outside the operating range. <IMAGE>
Patent DE-69731955-T2 (DE)
Inventor: NORTON J
IPC: A61Q19/00
Filed: 1997-06-13
Granted: 2005-12-22
Abstract: The invention relates to compositions which comprise at least one acid protease enzyme and an acidic buffer, the acidic buffer comprising an acid and a pharmaceutically or cosmetically acceptable carrier, which compositions are useful for treating skin conditions, diseases or disorders. <IMAGE>
Patent DE-69738104-T2 (DE)
Inventor: KARI HANNU H
IPC: H04L47/2491
Filed: 1997-03-24
Granted: 2008-05-29
Abstract: Because of bottlenecks, such as an air interface, queues may be formed in routers and long data transmissions may run so slowly that use of interactive applications is no longer sensible. In the routers of the invention, separate queues are formed for each service, quality of service, connection, subscriber and/or application/application class. The quality of service can be indicated by providing each packet with an identity indicating the quality, or a change in the quality can be signalled as separate messages.
Patent DE-69804891-T2 (DE)
Inventor: SATCHELL DONALD PRENTICE
IPC: C21B3/00
Filed: 1998-01-16
Granted: 2002-11-21
Abstract: An iron ore refining method in which a secondary reactor (24) is employed for partly reducing iron ore and partly oxidising a carbon containing substance to form partly reduced secondary iron ore, coal char and a calorific gas containing carbon dioxide and carbon monoxide in a ratio of not less than about 0.25. The calorific gas is separated from the partly reduced secondary iron ore and the coal char and the resulting heated solids are introduced into the primary reactor (10) without substantial cooling. All or part of the iron product is formed from the partly reduced iron ore produced in the primary reactor (10). Since the secondary reactor (24) operates at a lower temperature than the primary reactor, part of the iron product is processed at a lower temperature to reduce oxygen requirements for the refining and to increase thermal efficiency. <IMAGE>
Patent DE-69810509-T2 (DE)
Inventor: BOYNE MICHAEL
IPC: G02B6/28
Filed: 1998-10-21
Granted: 2003-09-25
Abstract: A device for spatially separating components of frequency in a primary radiation beam comprising means for separating the primary radiation beam into a plurality of secondary radiation beams, a plurality of electrically biasable waveguides forming a waveguide array, each for transmitting a secondary radiation beam to an output, wherein each waveguide has an associated optical delay line having a corresponding optical delay time, wherein each of the optical delay times is different. The device also comprises means for applying a variable electric field across each of the waveguides such that the phase of the secondary radiation beams transmitted through each may be varied by varying the electric field. The secondary radiation beams output from each of the waveguides interfere in a propagation region with a secondary radiation beam output from at least one of the other waveguides so as to form an interference pattern comprising one or more maximum at various positions in the propagation region.
Patent DE-69829182-T2 (DE)
Inventor: LOPEZ P
IPC: G01N33/553
Filed: 1998-04-10
Granted: 2005-12-29
Abstract: The invention provides a reagentless assay kit for analyte in a sample comprising a modular affinity assembly including at least one sensor unit comprising a ligand having binding affinity for the analyte (affinity module) operatively associated with a reporter probe (reporter module) responsive to changes in the sensor unit induced by analyte/receptor complex formation by transduction of a characteristic detectable signal. Assays employing the modular assembly are also provided.
Patent DE-69829277-T2 (DE)
Inventor: RAU MARTIN
IPC: F24D3/16
Filed: 1998-12-29
Granted: 2006-04-27
Abstract: The invention relates to a building consisting of at least one room (1) comprising a floor (2), a ceiling (3), side walls (4) and at least one outside wall (5), as well as heating means (11 - 14). The heating means are incorporated in a ceiling plate (7), which is supported some distance below the ceiling of said room. Air flow means (9) are provided in one of the walls, through which air flows over said ceiling plate into the room. In this manner it is possible to control the temperature in the room.
Patent DE-69922936-T2 (DE)
Inventor: WAETJEN FRANK
IPC: A61P25/00
Filed: 1999-03-30
Granted: 2005-12-08
Abstract: The present invention relates to the use of indole-2,3-dione-3-oxime derivatives in a method of combating diseases and disorders associated with or mediated by the release of excitatory amino acids.
Patent DE-69929681-T2 (DE)
Inventor: MCINTOSH R
IPC: A61K35/12
Filed: 1999-03-12
Granted: 2006-10-26
Abstract: Disclosed is a method of reducing an immune response to a transplant in a recipient by treating said recipient with an amount of mesenchymal stem cells effective to reduce or inhibit host rejection of the transplant. The mesenchymal stem cells can be administered before, at the same time as, or after the transplant. Also disclosed is a method of inducing a reduced immune response against a host by foreign tissue, i.e., graft versus host disease, by treatment with mesenchymal stem cells.
Patent DE-69931215-T2 (DE)
Inventor: HAMILTON KEITH S
IPC: H04L1/00
Filed: 1999-06-28
Granted: 2006-10-12
Abstract: In a network with a sending system networked to at least one receiving system, it is sometimes desirable to transfer relatively short messages between the sending system and one or more receiving systems in a highly reliable yet highly efficient manner. The present invention defines two short message protocols, one of which relies on a statistical model and the other of which uses positive acknowledgement to track receipt of transmitted packets by intended recipient. The statistical reliability mode is based on the observation that for each packet in a message that is transmitted, the probability that at least one packet of the message is received by a given system increases. Thus, in the statistical reliability mode messages are divided into a guaranteed minimum number of packets, with additional packets being added if the message length is insufficient to fill the minimum number of packets. The positive reliability mode of the present invention periodically sets an acknowledgement flag in the packets transmitted for a message. Receiving systems send an acknowledgement in response to receipt of that packet. The sending system tracks receipt of acknowledgements by intended recipient and retransmits any unacknowledged packets so as to positively assure the packets are received. Receiving systems send negative acknowledgements to request retransmission of missing packets. Negative acknowledgement suppression is implemented at both the sender and receiver to prevent a flood of negative acknowledgements from overwhelming the network. Packets are transmitted by the sending system at a transmission rate selected to avoid any adverse impact on the packet loss rate of the network. <IMAGE>
Patent DE-69931387-T2 (DE)
Inventor: MALONE THOMAS G
IPC: B65D81/38
Filed: 1999-09-17
Granted: 2007-02-01
Abstract: An insulating bag is provided having an inflatable, double outer layer defining an interior container space for thermally-sensitive cargo. A surface reflective to radiant thermal energy lies within the inflated outer layer as a layer on an interior surface of the wall and/or as a surface formed on a baffle material lying within the inflated layer. The inner and outer layers of the double outer layers are attached to one-another in a series of attachment seams that together comprise configuration segments that, when inflated, provide structural definition to the interior containment space.
Patent DE-69933347-T2 (DE)
Inventor: KASHIWAGI ATSUNORI
IPC: C07D475/04
Filed: 1999-02-26
Granted: 2007-05-03
Abstract: It is an object of the present invention to provide a pharmaceutical composition for effectively preventing or improving diseases having vascular dysfunction associated with insulin resistance. The present invention provides pharmaceutical compositions for preventing or treating diseases having vascular dysfunction associated with insulin resistance, comprising as an active ingredient a compound of the formula (I): <CHEM> wherein R<1> and R<2> each represents a hydrogen atom or taken together with each other represent a single bond, while R<3> represents -CH(OH)CH(OH)CH3, -CH(OCOCH3)CH(OCOCH3)CH3, -CH3, -CH2OH or a phenyl group when R<1> and R<2> each represents a hydrogen atom, or -COCH(OH)CH3 when R<1> and R<2> together represents a single bond, or a pharmaceutically acceptable salt thereof.
Patent DE-69934030-T2 (DE)
Inventor: KNUDSON EDWARD B
IPC: G06Q30/02
Filed: 1999-04-22
Granted: 2007-06-14
Abstract: A banner advertisement containing text graphics or video is provided adjacent to program listing displayed on program guide screen. The user is allowed to scroll the listings by positioning a highlight on the banner advertisement and cursor is activated. The advertisements containing video, is provided to user television equipment, by a video server. Several network nodes are used to provide television program to user television equipment. When user selects the banner advertisement, he is provided with an opportunity to tune the given channel. An independent claim is also included for implementation method of interactive television program guide method.
Patent HU-E030092-T2 (HU)
Title: AFFINITY MATURED CRIg VARIANTS
Inventor: SIDHU SACHDEV S
IPC: G01N33/68
Filed: 2009-05-06
Abstract: The present invention concerns affinity matured CRIg variants. In particular, the invention concerns CRIg variants having increased binding affinity to C3b and retaining selective binding to C3b over C3.
Patent HU-E030711-T2 (HU)
Title: Apparatus and Method for Packing Smoking Articles
Inventor: BRAY ANDREW JONATHAN
IPC: B65B65/02
Filed: 2004-11-30
Abstract: A method and apparatus for making a hinged lid side-by-side vertically hinged cigarette pack (10) having a first bundle (22) and a second bundle (23) of cigarettes is described. The machinery includes a first machine (30) to form a first foil wrapped bundle surrounded by a first inner frame, a second machine (31) for forming a second foil wrapped bundle surrounded by a second inner frame and a third machine (32) for combining the first and second foil wrapped bundle into a single hinged lid side-by-side vertically hinged pack.